Potential associations of adult nocturia. Results from a national prevalence study.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
03 2021
Historique:
revised: 03 01 2021
received: 15 10 2020
accepted: 04 01 2021
pubmed: 8 2 2021
medline: 12 6 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

To determine the prevalence of nocturia and associated risk factors in the Colombian population aged ≥18 years old. This is a cross-sectional population-based study conducted in 1060 participants in Colombia. Nocturia was assessed with the Spanish version of the ICIQ-OAB, using the ICS terminology. Descriptive statistics were used to evaluate nocturia prevalence. Logistic regression analysis was carried out to determine the association of nocturia with predefined variables. The prevalence of nocturia was 55.9% and it was more common in women than men (53.96% vs. 46.04%; p = .004). At least three episodes of nocturia were observed in 20.37% of the participants who had a severe alteration in their quality of life (p < .01). The bivariate model showed an association between nocturia and obesity (odds ratio [OR], 1.69; 90% confidence interval [CI]: 1.22-2.34), diabetes mellitus (OR, 2.99; 90% CI: 1.86-4.83), high blood pressure (OR, 2.04; 90% CI: 1.52-2.72), cardiovascular disease (OR, 1.75; 90% CI: 1.08 - 2.83), depression (OR, 1.89; 90% CI: 1.23-2.89), obstructive sleep apnea (OR, 1.70; 90% CI: 1.17 - 2.46), and childhood enuresis (OR, 1.45; 90% CI: 1.04-2.02). The multivariate model showed an association with obesity (OR, 2.0; 95% CI: 1.14 - 3.51) in women, as well as age ≥ 65 years (OR, 3.18; 95% CI: 1.26 - 8.02) and erectile dysfunction (OR, 3.44; 95% CI: 1.21 - 9.72) in men. Childhood enuresis was significantly associated with nocturia in both genders (OR, 1.61; 95% CI: 1.09 - 2.40 in women and OR, 1.66; 95% CI: 1.09-2.52 in men). There is a significant prevalence of nocturia in our population and a clear association with impaired quality of life. We consider important to inquire about history of childhood enuresis to define the risk of presenting nocturia in adulthood. Nocturia was associated with multiple comorbidities. Obesity and erectile dysfunction play an important role as modifiable risk factor.

Identifiants

pubmed: 33550620
doi: 10.1002/nau.24624
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-828

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Hashim H, Blanker MH, Drake MJ, Djurhuus JC, Meijlink J, Morris V. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38(2):499-508. https://doi.org/10.1002/nau.23917
Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, Brubaker L, Van Den Eeden SK. Childhood urinary symptoms predict adult overactive bladder symptoms. J Urol. 2006;175(3):989-993. https://doi.org/10.1016/S0022-5347%2805%2900416-7
Shadpour P, Shiehmorteza M. Enuresis persisting into adulthood. Urol J. 2006;3(3):117-129. http://www.ncbi.nlm.nih.gov/pubmed/17559026
Campbell P, Li W, Money-Taylor J, Davies J, Gray T, Radley S. Nocturnal enuresis: prevalence and associated LUTS in adult women attending a urogynaecology clinic. Int Urogynecol J. Vol 28, 2017:315-320. https://doi.org/10.1007/s00192-016-3099-0
Dani H, Esdaille A, Weiss JP. Nocturia: aetiology and treatment in adults. Nat Rev Urol. 2016;13(10):573-583. http://www.nature.com/articles/nrurol.2016.134
Weiss JP, Everaert K. Management of Nocturia and Nocturnal Polyuria. Urology. 2019;133:24-33. https://linkinghub.elsevier.com/retrieve/pii/S0090429519308507
Oelke M, De Wachter S, Drake MJ, Giannantoni A, Kirby M, Orme S. A practical approach to the management of nocturia. Int J Clin Pract. 2017;71(11):e13027. https://doi.org/10.1111/ijcp.13027
Soysal P, Cao C, Xu T, Yang L, Isik AT, Turan Kazancioglu R. Trends and prevalence of nocturia among US adults, 2005-2016. Int Urol Nephrol. 2020;52(5):805-813. https://doi.org/10.1007/s11255-019-02361-5
Plata M, Bravo-Balado A, Robledo D, Trujillo CG, Caicedo JI, Cataño JG. Prevalence of lower urinary tract symptoms and overactive bladder in men and women over 18 years old: the Colombian overactive bladder and lower urinary tract symptoms (COBaLT) study. Neurourol Urodyn. 2019;38(1):200-207. https://doi.org/10.1002/nau.23828
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urol. 2003;61(1):37-49.
Haylen BT, de Ridder D, Freeman RM. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;798:797-798.
Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2(2):175-184. http://journals.lww.com/00006396-197606000-00006
Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471-481. https://doi.org/10.1002/nau.22751
Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230-237. https://doi.org/10.1002/nau.22295
Madhu C, Coyne K, Hashim H, Chapple C, Milsom I, Kopp Z. Nocturia: risk factors and associated comorbidities; findings from the EpiLUTS study. Int J Clin Pract. 2015;69(12):1508-1516. https://doi.org/10.1111/ijcp.12727
Bosch JLHR, Weiss JP. The prevalence and causes of nocturia. J Urol. 2013;189(1S), https://doi.org/10.1016/j.juro.2012.11.033
Cornu J-N, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management-a systematic review and meta-analysis. Eur Urol. 2012;62(5):877-890. https://linkinghub.elsevier.com/retrieve/pii/S0302283812008093
Wang J-Y, Liao L, Liu M, Sumarsono B, Cong M. Epidemiology of lower urinary tract symptoms in a cross-sectional, population-based study. Medicine. 2018;97(34):e11554. http://journals.lww.com/00005792-201808240-00003
Wen L, Wen YB, Wang ZM, Wen JG, Li ZZ, Shang XP. Risk factors of nocturia (two or more voids per night) in Chinese people older than 40 years. Neurourol Urodyn. 2015;34(6):566-570. https://doi.org/10.1002/nau.22623
Soler R, Gomes CM, Averbeck MA, Koyama M. The prevalence of lower urinary tract symptoms (LUTS) in Brazil: Results from the epidemiology of LUTS (Brazil LUTS) study. Neurourol Urodyn. 2018;37(4):1356-1364. https://doi.org/10.1002/nau.23446
Moreira ED, Neves RCS, Neto AF, Duarte FG, Moreira TL, Lobo CFL. A Population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES). World J Urol. 2013;31(6):1451-1458. https://doi.org/10.1007/s00345-013-1057-8
Chow P-M, Liu S-P, Chuang Y-C, Lee K-S, Yoo TK, Liao L. The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study. World J Urol. 2018;36(11):1853-1862. https://doi.org/10.1007/s00345-018-2329-0
Tikkinen KAO, Auvinen A, Johnson TM, Weiss JP, Keränen T, Tiitinen A. A systematic evaluation of factors associated with nocturia-the population-based FINNO study. Am J Epidemiol. 2009;170(3):361-368. https://doi.org/10.1093/aje/kwp133
Lowenstein L, Kenton K, Brubaker L, Pillar G, Undevia N, Mueller ER. The relationship between obstructive sleep apnea, nocturia, and daytime overactive bladder syndrome in women. Am J Obstet Gynecol. 2008;198(5):598. e1-598.e5. https://linkinghub.elsevier.com/retrieve/pii/S0002937808001683
Parthasarathy S, Fitzgerald M, Goodwin JL, Unruh M, Guerra S, Quan SF. Nocturia, sleep-disordered breathing, and cardiovascular morbidity in a community-based cohort. PLOS One. 2012;7(2):e30969. https://doi.org/10.1371/journal.pone.0030969
Zhou J, Xia S, Li T, Liu R. Association between obstructive sleep apnea syndrome and nocturia: a meta-analysis. Sleep Breath. 2020;24:1293-1298. https://doi.org/10.1007/s11325-019-01981-6
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637-649. https://linkinghub.elsevier.com/retrieve/pii/S0302283803004640
Choi WS, Song WH, Park J, Yoo S, Son H. Relationship between each IPSS item score and erectile dysfunction in the Korean Internet Sexuality Survey (KISS): do men with weak streams have low sexual function? World J Urol. 2020;38:3219-3226. https://doi.org/10.1007/s00345-020-03128-9
Mariappan P, Chong WL. Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction, and incontinence in men from a multiethnic Asian population: results of a regional population-based survey and comparison with industrialized nations. BJU Int. 2006;98(6):1264-1268. https://doi.org/10.1111/j.1464-410X.2006.06525.x
Aslan G, Cavus E, Karas H, Oner O, Duran F, Esen A. Association between lower urinary tract symptoms and erectile dysfunction. Arch Androl. 2006;52(3):155-162. https://doi.org/10.1080/01485010500379871
Vaughan CP, Auvinen A, Cartwright R, Johnson TM, Tähtinen RM, Ala-Lipasti MA. Impact of obesity on urinary storage symptoms: results from the FINNO study. J Urol. 2013;189(4):1377-1382. https://doi.org/10.1016/j.juro.2012.10.058
Moon S, Chung HS, Yu JM, Ko KJ, Choi DK, Kwon O. The association between obesity and the nocturia in the U.S. population. Int Neurourol J. 2019;23(2):169-176. https://doi.org/10.5213/inj.1938062.031
Lai HH, Helmuth ME, Smith AR, Wiseman JB, Gillespie BW, Kirkali Z. Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms. Urology. 2019;123:34-43. https://linkinghub.elsevier.com/retrieve/pii/S0090429518309981
Vandersteen DR, Husmann DA. Treatment of primary nocturnal enuresis persisting into adulthood. J Urol. 1999;161(1):90-92. http://www.ncbi.nlm.nih.gov/pubmed/10037376
Othman JA-M, Åkervall S, Molin M, Gyhagen M. Childhood nocturnal enuresis-a marker for pelvic floor disorders and urinary tract symptoms in women? Int Urogynecol J. 2020. https://doi.org/10.1007/s00192-020-04345-x
Akashi S, Tomita K. The impact of a history of childhood nocturnal enuresis on adult nocturia and urgency. Acta Paediatr. 2014;103(9):e410-e415. https://doi.org/10.1111/apa.12694
Goessaert A-S, Everaert K, Hoebeke P, Kapila A, Walle JV. Nocturnal enuresis and nocturia, differences and similarities-lessons to learn? Acta Clin Belg. 2015;70(2):81-86. https://doi.org/10.1179/2295333714Y.0000000055
Goessaert A-S, Schoenaers B, Opdenakker O, Hoebeke P, Everaert K, Vande Walle J. Long-term followup of children with nocturnal enuresis: increased frequency of nocturia in adulthood. J Urol. 2014;191(6):1866-1871. https://doi.org/10.1016/j.juro.2013.12.051
Oriá MOB, Mitchell EM, Vasconcelos CTM, de Oliveira TDA, Lopes LG, de Menezes PR. Prevalence of lower urinary tract symptoms and social determinants in primary care users in Brazil. Int Urogynecol J. 2018; 29(12):1825-1832. https://doi.org/10.1007/s00192-018-3635-1
Kim SY, Bang W, Kim M-S, Park B, Kim J-H, Choi HG. Analysis of the prevalence and factors associated with nocturia in adult Korean men. Sci Rep. 2017;7(1):41714. http://www.nature.com/articles/srep41714
Hanna JS, Herrera-Almario GE, Pinilla-Roncancio M, Tulloch D, Valencia SA, Sabatino ME기타. Use of the six core surgical indicators from the Lancet Commission on Global Surgery in Colombia: a situational analysis. Lancet Glob Heal. 2020;8(5):e699-e710. https://linkinghub.elsevier.com/retrieve/pii/S2214109X20300905

Auteurs

Julian Azuero (J)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Jessica Santander (J)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Carlos Gustavo Trujillo (CG)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Juan Ignacio Caicedo (JI)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Laura Zuluaga (L)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Ana María Becerra (AM)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Fabián Daza (F)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Martin Rondón (M)

Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá, Colombia.

Mauricio Plata (M)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH